1192548-07-4 Usage
Uses
Used in Organic Synthesis:
1-Bromo-3-nitro-2-(trifluoromethyl)benzene is utilized as a starting material in organic synthesis for the preparation of various chemicals and pharmaceuticals. Its unique functional groups and structural features make it a valuable intermediate in the synthesis of a wide range of compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-Bromo-3-nitro-2-(trifluoromethyl)benzene is used as a building block for the development of new drugs. Its specific functional groups can be modified or reacted to create novel drug candidates with potential therapeutic applications.
Used in Agrochemical Production:
1-Bromo-3-nitro-2-(trifluoromethyl)benzene is also employed in the production of agrochemicals. Its reactivity and structural properties allow it to be incorporated into the synthesis of various agrochemicals, such as pesticides and herbicides, to improve their efficacy and selectivity.
Used in Advanced Materials:
1-BroMo-3-nitro-2-(trifluoroMethyl)benzene is used as a building block in the development of advanced materials, such as polymers and coatings, with specific properties tailored for various applications. Its unique combination of functional groups and structural features contributes to the creation of materials with improved performance characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1192548-07-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,5,4 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1192548-07:
(9*1)+(8*1)+(7*9)+(6*2)+(5*5)+(4*4)+(3*8)+(2*0)+(1*7)=164
164 % 10 = 4
So 1192548-07-4 is a valid CAS Registry Number.
1192548-07-4Relevant academic research and scientific papers
AMINO ACID COMPOUNDS
-
Page/Page column 52, (2009/12/23)
[Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. [Solving Means] Amino acid compounds that are represented by the following Formula (1) are provided
